Top Markets
#1 Trillions Trillions +5,128.37%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +163.86%
#4 Siren Siren +91.29%
#5 KONET KONET +60.65%
#6 inSure DeFi inSure DeFi +59.52%
#7 Banana For Scale Banana For Scale +44.28%
#8 Aria.AI Aria.AI +38.69%
#9 Syndicate Syndicate +37.36%
#10 Janction Janction +32.88%
Coin of the day
Trillions Trillions
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Classifica tra le azioni #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Prezzo delle azioni
$0.09933121
Capitalizzazione di mercato
$29.15K
Variazione (1 giorno)
0.57%
Variazione (1 anno)
449.49%
Paese
IE
Scambia Ovoca Bio plc (OVB)

Categoria

Healthcare
Rapporto P/B per Ovoca Bio plc (OVB)
Rapporto P/B al March 2026 TTM: 0.32
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Ovoca Bio plc, il rapporto P/B attuale (TTM) è 0.32. Alla fine del 2022, era pari a 0.64.
Storico del rapporto P/B per Ovoca Bio plc da 2001 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.32 5.10%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 1,694.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 1,924.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 678.66%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 1,284.08%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 1,772.31%
NL